Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 AUD | 0.00% | +20.00% | -57.14% |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Capitalization 1 | 18.95 | 15.86 | 6.02 | 2.395 |
Enterprise Value (EV) 1 | 14.44 | 11.78 | 4.532 | 2.584 |
P/E ratio | -2.13 x | -2.88 x | -1.24 x | -0.64 x |
Yield | - | - | - | - |
Capitalization / Revenue | 10.1 x | 5.22 x | 2.04 x | 0.8 x |
EV / Revenue | 7.72 x | 3.87 x | 1.54 x | 0.87 x |
EV / EBITDA | -6.45 x | -2.54 x | -1.05 x | -0.85 x |
EV / FCF | -17,364,848 x | -6,150,987 x | -1,408,677 x | -1,964,052 x |
FCF Yield | -0% | -0% | -0% | -0% |
Price to Book | 4.38 x | 4.09 x | 2.9 x | -13.5 x |
Nbr of stocks (in thousands) | 94,714 | 118,075 | 148,307 | 251,227 |
Reference price 2 | 0.2000 | 0.1343 | 0.0406 | 0.009534 |
Announcement Date | 3/25/21 | 3/30/22 | 3/31/23 | 3/28/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 0.524 | 1.184 | 1.87 | 3.04 | 2.947 | 2.984 |
EBITDA 1 | 0.158 | -2.103 | -2.239 | -4.633 | -4.321 | -3.048 |
EBIT 1 | 0.157 | -2.112 | -2.249 | -4.733 | -4.344 | -3.071 |
Operating Margin | 29.96% | -178.38% | -120.27% | -155.69% | -147.4% | -102.92% |
Earnings before Tax (EBT) 1 | 0.07 | -2.027 | -4.36 | -4.78 | -4.249 | -2.893 |
Net income 1 | -0.044 | -2.031 | -4.361 | -4.78 | -4.249 | -2.893 |
Net margin | -8.4% | -171.54% | -233.21% | -157.24% | -144.18% | -96.95% |
EPS 2 | -0.001205 | -0.0556 | -0.0940 | -0.0466 | -0.0328 | -0.0150 |
Free Cash Flow | - | -1.081 | -0.8316 | -1.915 | -3.217 | -1.316 |
FCF margin | - | -91.28% | -44.47% | -62.99% | -109.17% | -44.09% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 10/28/20 | 10/28/20 | 3/25/21 | 3/30/22 | 3/31/23 | 3/28/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | 0.19 |
Net Cash position 1 | 2.4 | 0.59 | 4.51 | 4.08 | 1.49 | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | -0.062 x |
Free Cash Flow | - | -1.08 | -0.83 | -1.91 | -3.22 | -1.32 |
ROE (net income / shareholders' equity) | - | -139% | -177% | -117% | -143% | -305% |
ROA (Net income/ Total Assets) | - | -74.1% | -46.3% | -59.4% | -69.9% | -96.8% |
Assets 1 | - | 2.741 | 9.41 | 8.044 | 6.079 | 2.988 |
Book Value Per Share 2 | 0.0600 | 0.0200 | 0.0500 | 0.0300 | 0.0100 | -0 |
Cash Flow per Share 2 | 0.0700 | 0.0200 | 0.0500 | 0.0400 | 0.0100 | 0 |
Capex 1 | 0.01 | 0.02 | 0.01 | 0 | 0 | - |
Capex / Sales | 2.48% | 1.27% | 0.27% | 0.13% | 0.14% | - |
Announcement Date | 10/28/20 | 10/28/20 | 3/25/21 | 3/30/22 | 3/31/23 | 3/28/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-57.14% | 983K | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- NGS Stock
- Financials Nutritional Growth Solutions Ltd.